,

Antibiotic Discovery and Development

Specificaties
Gebonden, 1127 blz. | Engels
Springer US | 2012e druk, 2011
ISBN13: 9781461413998
Rubricering
Springer US 2012e druk, 2011 9781461413998
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

This volume covers all aspects of the antibiotic discovery and development process through Phase II/III. The contributors, a group of highly experienced individuals in both academics and industry, include chapters on the need for new antibiotic compounds, strategies for screening for new antibiotics, sources of novel synthetic and natural antibiotics, discovery phases of lead development and optimization, and candidate compound nominations into development. Beyond discovery , the handbook will cover all of the studies to prepare for IND submission: Phase I (safety and dose ranging), progression to Phase II (efficacy), and Phase III (capturing desired initial indications). This book walks the reader through all aspects of the process, which has never been done before in a single reference. With the rise of antibiotic resistance and the increasing view that a crisis may be looming in infectious diseases, there are strong signs of renewed emphasis in antibiotic research. The purpose of the handbook is to offer a detailed overview of all aspects of the problem posed by antibiotic discovery and development.

Specificaties

ISBN13:9781461413998
Taal:Engels
Bindwijze:gebonden
Aantal pagina's:1127
Uitgever:Springer US
Druk:2012

Inhoudsopgave

<p>Introductory History of Antimicrobial Drugs.- Marketed Major Classes of Compounds.- The Rise of Antibiotic Resistance/Resistance Mechanisms to Major Classes.- Clinical Issues of Resistance: “Worst Offenders” List of Problematic Microbes.- Antibiotic Discovery.- Antibiotic Drug Development.- The Economics and Incentives of Antibiotic Drug Discovery.</p>

Rubrieken

    Personen

      Trefwoorden

        Antibiotic Discovery and Development